Inherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the ...

One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...

A subretinal injection of ATSN-201 gene therapy demonstrated promising results in patients with X-linked retinoschisis in a ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Government employee regains sight after 6 years of vision loss due to rare autoimmune condition at Rajan Eye Care Hospital.

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...

In this video, Jay Chhablani, MD, discusses findings presented at the ARVO meeting from a phase 2b study evaluating suprachoroidal axitinib for neovascular age-related macular degeneration.

Berlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products ...